Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis and a history of nonsteroidal immunosuppressant use: a post hoc analysis of the phase III CAFE trial
Bouaziz J-D., Ogg G., de Bruin-Weller M., Bieber T., Irvine A., Shumel B., Msihid J., Rossi AB.